The SCCS has published its final opinion on the cosmetic ingredient Kojic Acid. On November 5, 2021, the preliminary version of the SCCS opinion on the ingredient Kojic Acid was published. Currently, this ingredient is used in cosmetic products as an antioxidant. It...
Legal Cosmetic Area
Sodium Bromothymol Blue (C186) – New mandate for the evaluation of cosmetic ingredients
The scientific opinion of the SCCS of the cosmetic ingredient Sodium Bromothymol Blue (C186) on its safety in colorants is requested. The cosmetic Sodium Bromothymol Blue (C186) (CAS No. 34722-90-2, EC No. 252-169-7) with the chemical name 'Sodium α-...
Meeting of the Working Group on methodologies
On March 4, the meeting of the SCCS Working Group on methodologies took place. The following topics were discussed at this meeting: SSCS Review of Notes of Guidance New Approach Methodologies (NAMs) to address local inhalation effects in case of complex natural...
Meeting of the Working Group on methodologies
On February 24, the meeting of the SCCS Working Group on methodologies took place. The following topics were discussed at this meeting: SSCS Review of Notes of Guidance New science program The next group meeting will take place on March 4, 2022. You can view the full...
Meeting of the Working Group on Cosmetic Ingredients
On February 8 and 9, the meeting of the SCCS Working Group on cosmetic ingredients took place. During the meeting, various points related to new mandates or information from DG Grow, draft opinions and comments on opinions were discussed. First of all, the following...
Citral – New mandate for the evaluation of cosmetic ingredients
The scientific opinion of the SCCS of the cosmetic ingredient Citral on the sensitization endpoint is requested. Citral (CAS No. 5392-40-5, EC No. 226-394-6) with the chemical name ‘3,7-Dimethyl-2,6- octadienal’ is a mixture of neral and geranial, which are...
Working Group meeting on Nanomaterials
On February 4, the SCCS Nanomaterials Working Group met to address issues that are currently in process. The following draft opinions were discussed at the Working Group meeting: Fullerenes: Letters to Notifiers were finalised and adopted by SCCS Silica: industry has...
Working Group meeting on Nanomaterials
On January 20, the SCCS Nanomaterials Working Group met to address issues that are currently in process. The following draft opinions were discussed at the Working Group meeting: Fullerenes New dossiers received on Silica (nano) (Silica, Hydrated Silica, Silica...
Prostaglandins and prostaglandin-analogues – Final Opinion
The SCCS has published its final opinion on the cosmetic ingredient Prostaglandins and their analogs. On September 28, 2021, the preliminary version of the SCCS opinion on the ingredient Prostaglandins and their analogs was published. The conclusions of the SCCS...
Salicylic Acid – Request for a scientific opinion
The Commission has requested the SCCS to carry out a safety assessment of Salicylic acid as a substance with possible endocrine disrupting properties. General situation On 7 November 2018, the Commission adopted the review of Regulation (EC) No 1223/2009 on cosmetic...
Benzyl Salicylate – Request for a scientific opinion
The Commission has requested the SCCS to carry out a safety assessment of Benzyl Salicylate as a substance with possible endocrine disrupting properties. General situation On 7 November 2018, the Commission adopted the review of Regulation (EC) No 1223/2009 on...
Methylparaben – Request for a scientific opinion
The Commission has requested the SCCS to carry out a safety assessment of Methylparaben as a substance with possible endocrine disrupting properties. General situation On 7 November 2018, the Commission adopted the review of Regulation (EC) No 1223/2009 on cosmetic...


